[1]
“Safety and Efficacy of Oral Brivaracetam versus Levetiracetam as Monotherapy in Children Aged 1 Month to 14 Years with Newly Diagnosed Epilepsy”, Pjmcr, vol. 4, no. 2, pp. 876–883, Jun. 2025, Accessed: May 17, 2026. [Online]. Available: http://pakjmcr.com/index.php/1/article/view/450